Recognition and management of neonatal hemodynamic compromise

• Wu T.W.
• Shahab Noori

Abstract

Hemodynamic compromise of the neonate can occur in various clinical situations, including but not limited to maladaptation during the early transitional period, sepsis, congenital heart anomalies, hemodynamically significant patent ductus arteriosus, persistent pulmonary hypertension of the newborn, systemic inflammatory diseases such as necrotizing enterocolitis, and dehydration.

Despite the handful of advances in neonatal care through ground-breaking clinical trials, the management of neonatal shock is often dependent on the bedside clinician's experience and training without the aid of high-level evidence. However, the recognition for the importance of comprehensive and serial hemodynamic assessment is growing. There is now a wealth of literature investigating the use of functional echocardiography, nearinfrared spectroscopy, and noninvasive impedance-based cardiometry to complement common bedside hemodynamic measures such as blood pressure and heart rate measurement.

In this review article, the pathophysiology of neonatal hemodynamic compromise is outlined, and concomitant best-evidence management for hemodynamic compromise in the neonate is proposed.

Keywords:hypotension, inotrope, preterm, shock, vasopressor

REFERENCES

1. Noori S., Seri I. Evidence-based versus pathophysiology-based approach to diagnosis and treatment of neonatal cardiovascular compromise. Semin Fetal Neonatal Med. 2015; 20: 238-45.

2. Nuntnarumit P., Yang W., Bada-Ellzey H.S. Blood pressure measurements in the newborn. Clin Perinatol. 1999; 26: 981-96.

3. Munro M.J., Walker A.M., Barfield C.P. Hypotensive extremely low birth weight infants have reduced cerebral blood flow. Pediatrics. 2004; 114: 1591-6.

4. Stranak Z., Semberova J., Barrington K., O’Donnell C., Marlow N., Naulaers G., et al. International survey on diagnosis and management of hypotension in extremely preterm babies. Eur J Pediatr. 2014; 173: 793-8.

5. Durrmeyer X., Marchand-Martin L., Porcher R., Gascoin G., Roze J.C., Storme L., et al. Abstention or intervention for isolated hypotension in the first 3 days of life in extremely preterm infants: association with short-term outcomes in the EPIPAGE 2 cohort study. Arch Dis Child Fetal Neonatal Ed. 2017; 102: 490-6.

6. Al-Aweel I., Pursley D.M., Rubin L.P, Shah B., Weisberger S., Richardson D.K. Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Perinatol. 2001; 21: 272-8.

7. Lasky T., Greenspan J., Ernst F.R., Gonzalez L. Dopamine and dobu-tamine use in preterm or low birth weight neonates in the premier 2008 database. Clin Ther. 2011; 33: 2082-8.

8. Batton B., Li L., Newman N.S., Das A., Watterberg K.L., Yoder B.A., et al. Use of antihypotensive therapies in extremely preterm infants. Pediatrics. 2013; 131: e1865-73.

9. Kluckow M., Evans N. Relationship between blood pressure and cardiac output in preterm infants requiring mechanical ventilation. J Pediatr. 1996; 129: 506-12.

10. Hsu K.H., Wu T.W., Wu I.H., Lai M.Y., Hsu S.Y., Huang H.W., et al. Electrical cardiometry to monitor cardiac output in preterm infants with patent ductus arteriosus: a comparison with echocardiography. Neonatology. 2017; 112: 231-7.

11. Noori S., Seri I. Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents. Clin Perinatol. 2012; 39: 221-38.

12. Wu T.W., Azhibekov T., Seri I. Transitional hemodynamics in preterm neonates: clinical relevance. Pediatr Neonatol. 2016; 57: 7-18.

13. Oca M.J., Nelson M., Donn S.M. Randomized trial of normal saline versus 5% albumin for the treatment of neonatal hypotension. J Perinatol. 2003; 23: 473-6.

14. Lynch S.K., Mullett M.D., Graeber J.E., Polak M.J. A comparison of albumin-bolus therapy versus normal saline-bolus therapy for hypotension in neonates. J Perinatol. 2008; 28: 29-33.

15. Keir A.K., Karam O., Hodyl N., Stark M.J., Liley H.G., Shah P.S., et al. International, multicentre, observational study of fluid bolus therapy in neonates. J Paediatr Child Health. 2019; 55: 632-9.

16. Lehtiranta S., Honkila M., Kallio M., Paalanne N., Peltoniemi O., Pokka T., et al. Risk of electrolyte disorders in acutely ill children receiving commercially available plasmalike isotonic fluids: a randomized clinical trial. JAMA Pediatr. 2021; 175 (1): 28-35.

17. Brown R.M., Wang L., Coston T.D., Krishnan N.I., Casey J.D., Wanderer J.P., et al. Balanced crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial. Am J Respir Crit Care Med. 2019; 200: 1487-95.

18. Giesinger R.E., Bailey L.J., Deshpande P., McNamara PJ. Hypoxi-cischemic encephalopathy and therapeutic hypothermia: the hemodynamic perspective. J Pediatr. 2017; 180: 22-30.e2.

19. Shah P., Riphagen S., Beyene J., Perlman M. Multiorgan dysfunction in infants with post-asphyxial hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2004; 89: F152-5.

20. Mertens L., Seri I., Marek J., Arlettaz R., Barker P., McNamara P., et al. Targeted neonatal echocardiography in the neonatal intensive care unit: practice guidelines and recommendations for training. Writing group of the American society of echocardiography (ASE) in collaboration with the European association of echocardiography (EAE) and the association for European pediatric cardiologists (AEPC). J Am Soc Echocardiogr. 2011; 24: 1057-78.

21. Rios D.R., Moffett B.S., Kaiser J.R. Trends in pharmacotherapy for neonatal hypotension. J Pediatr. 2014; 165: 697-701.e1.

22. Subhedar N.V., Shaw N.J. Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev. 2003; 3: CD001242.

23. Noori S., Friedlich P., Seri I. Pharmacology review: The use of dobutamine in the treatment of neonatal cardiovascular compromise. Neoreviews. 2004; 5: e22-6.

24. Robel-Tillig E., Knupfer M., Pulzer F., Vogtmann C. Cardiovascular impact of dobutamine in neonates with myocardial dysfunction. Early Hum Dev. 2007; 83: 307-12.

25. Noori S., McCoy M., Anderson M.P., Ramji F., Seri I. Changes in cardiac function and cerebral blood flow in relation to peri-/intraventricular hemorrhage in extremely preterm infants. J Pediatr. 2014; 164: 264-70. e1-3.

26. Kluckow M., Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2000; 82: F188-94.

27. Paradisis M., Evans N., Kluckow M., Osborn D. Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr. 2009; 154: 189-95.

28. Osborn D., Evans N., Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr. 2002; 140: 183-91.

29. Bravo M.C., Lopez-Ortego P., Sanchez L., Riera J., Madero R., Cabanas F., et al. Randomized, placebo-controlled trial of dobutamine for low superior vena cava flow in infants. J Pediatr. 2015; 167: 572-578.e1-2.

30. de Waal K., Evans N. Hemodynamics in preterm infants with late-onset sepsis. J Pediatr. 2010; 156: 918-922.e1.

31. Saini S.S., Kumar P., Kumar R.M. Hemodynamic changes in preterm neonates with septic shock: a prospective observational study. Pediatr Crit Care Med. 2014; 15: 443-50.

32. Raj S., Killinger J.S., Gonzalez J.A., Lopez L. Myocardial dysfunction in pediatric septic shock. J Pediatr. 2014; 164: 72-7.e2.

33. Williams F.Z., Sachdeva R., Travers C.D., Walson K.H., Hebbar K.B. Characterization of myocardial dysfunction in fluid- and catecholamine-refractory pediatric septic shock and its clinical significance. J Intensive Care Med. 2016; 34: 17-25.

34. Seri I. Management of hypotension and low systemic blood flow in the very low birth weight neonate during the first postnatal week. J Perinatol. 2006; 26: S8-13.

35. Valverde E., Pellicer A., Madero R., Elorza D., Quero J., Cabanas F. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes. Pediatrics. 2006; 117: e1213-22.

36. Pellicer A., Valverde E., Elorza M.D., Madero R., Gaya F., Quero J., et al. Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics. 2005; 115: 1501-12.

37. Baske K., Saini S.S., Dutta S., Sundaram V. Epinephrine versus dopamine in neonatal septic shock: a double-blind randomized controlled trial. Eur J Pediatr. 2018; 177: 1335-42.

38. Rhodes A., Evans L.E., Alhazzani W., Levy M.M., Antonelli M., Ferrer R., et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017; 43: 304-77.

39. Rizk M., Lapointe A., Lefebvre F., Barrington K.J. Norepinephrine infusion improves haemodynamics in the preterm infants during septic shock. Acta Paediatr. 2018; 107: 408-13.

40. Rowcliff K., de Waal K., Mohamed A.L., Chaudhari T. Noradrenaline in preterm infants with cardiovascular compromise. Eur J Pediatr. 2016; 175: 1967-73.

41. Rios D.R., Kaiser J.R. Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study. J Pediatr. 2015; 166: 850-5.

42. Khare C., Adhisivam B., Bhat B.V., Vaishnav D. Utility of low dose vasopressin for persistent pulmonary hypertension of newborn with catecholamine refractory shock. Indian J Pediatr. 2021; 88 (5): 450-4. DOI: https://doi.org/10.1007/s12098-020-03519-1

43. Boyd S.M., Riley K.L., Giesinger R.E., McNamara PJ. Use of vasopressin in neonatal hypertrophic obstructive cardiomyopathy: case series. J Perinatol. 2021; 41 (1): 126-33. https://doi.org/10.1038/s41372-020-00824-7

44. Kumbhat N., Noori S. Corticosteroids for neonatal hypotension. Clin Perinatol. 2020; 47: 549-62.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)